Alivus Life Sciences Financials

NSE: GLS | BSE: 543322

₹1,360.80

up-down-arrow12.40 (0.92%)

As on 26-Aug-2026IST

Market cap

info icon

₹16,697 Cr

Revenue (TTM)

info icon

₹2,590 Cr

P/E Ratio

info icon

27.7

P/B Ratio

info icon

4.8

Div. Yield

info icon

0.4 %

Income Statement (₹ Cr)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Operating Revenue
2,590.40
2,551.83
2,386.88
2,283.21
2,161.22
2,123.21
Total Income
2,664.23
2,612.24
2,421.45
2,295.26
2,190.18
2,137.92
Total Expenditure
1,753.71
1,754.55
1,704.30
1,608.97
1,518.93
1,507.15
EBITDA
836.69
797.28
682.58
674.25
642.29
616.06
Depreciation
78.88
75.36
60.61
53.45
42.09
37.88
EBIT
757.81
721.93
621.98
620.79
600.20
578.18
Interest
5.43
5.37
2.41
1.55
0.55
27.96
Other Income
73.83
60.41
34.57
12.04
28.96
14.70
Exceptional Items
-25.66
-25.66
--
--
--
--
Profit before Tax
800.55
751.31
654.13
631.29
628.61
564.93
Provision for Tax
197.53
186.83
168.50
160.40
161.65
146.20
Profit after Tax
603.02
564.48
485.63
470.89
466.96
418.72

Liabilities (₹ Cr)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Shareholder's Funds
3,332.13
3,332.13
2,817.37
2,332.32
2,138.21
2,054.31
Minority Interest
--
--
--
--
--
--
Non-Current Liabilities
142.73
142.73
466.05
756.95
67.40
32.70
Current Liabilities
508.04
682.24
470.16
438.77
1,014.89
746.80
Total Liabilities
3,982.90
4,157.10
3,753.59
3,528.05
3,220.49
2,833.81

Assets (₹ Cr)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Non-Current Assets
1,321.38
1,333.54
1,418.43
1,612.05
851.81
706.42
Current Assets
2,649.36
2,823.56
2,335.16
1,916.00
2,368.68
2,127.39
Total Assets
3,982.90
4,157.10
3,753.59
3,528.05
3,220.49
2,833.81
Total Debt*
--
--
--
--
--
--
Net Current Assets
2,141.33
2,141.33
1,865.00
1,477.23
1,353.80
1,380.59
Contingent Liabilities
--
4.82
4.82
4.82
2.22
2.22

Cashflow (₹ Cr)

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Cash From Operating Activities
--
565.41
391.52
413.52
306.01
597.59
Cash Flow from Investing Activities
--
-570.15
-615.65
-116.48
-146.75
-122.23
Cash from Financing Activities
--
-64.34
-6.23
-279.44
-387.59
-78.80
Net Cash Inflow / Outflow
--
-69.08
-230.35
17.59
-228.33
396.56

Financials Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Adjusted EPS (₹) info
50.73
45.99
39.63
38.43
38.11
34.17
Cash EPS (₹) info
49.12
52.13
44.58
42.79
41.55
37.27
Adjusted Book Value (₹) info
283.86
270.90
229.11
189.45
173.97
167.38
Dividend per Share (₹) info
0.37
5.00
5.00
22.50
21.00
21.00
Cash Flow per Share (₹) info
--
46.07
31.95
33.75
24.98
48.77
Free Cash Flow per Share (₹) info
--
16.64
16.30
21.33
10.82
34.63

Profitability Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
ROCE (%) info
--
24.61
25.50
28.31
30.01
42.24
ROE (%) info
19.61
18.41
18.94
21.15
22.33
29.87
ROA (%) info
16.31
14.27
13.34
13.96
15.43
16.57
EBIT Margin (%) info
29.25
28.29
26.06
27.19
27.77
27.23
Net Margin (%) info
22.63
21.61
20.06
20.52
21.32
19.59
Cash Profit Margin (%) info
--
24.81
22.79
22.90
23.43
21.48

Growth Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Revenue Growth (%) info
7.93
6.91
4.54
5.64
1.79
12.63
EBIT Growth (%) info
19.88
16.07
0.19
3.43
3.81
3.68
Net Profit Growth (%) info
25.58
16.24
3.13
0.84
11.52
19.10
EPS Growth (%) info
21.50
16.05
3.12
0.84
11.52
4.78
Book Value Growth (%) info
--
18.43
20.94
8.90
3.94
172.44

Valuation Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Price / Earnings info
27.69
21.18
27.24
20.17
10.28
13.43
Price / Book Value info
4.79
3.60
4.71
4.09
2.25
2.74
Dividend Yield (%) info
0.37
0.51
0.46
2.90
5.36
4.58
EV/EBITDA info
18.34
13.94
18.35
13.40
6.69
8.10
Close Price (₹) info
1,156.50
972.70
1,081.15
776.65
392.90
458.80
High Price (₹) info
1,176.90
1,225.10
1,335.10
906.00
534.00
799.95
Low Price (₹) info
819.00
819.00
743.60
375.95
369.00
376.00
Market Cap (₹ Cr) info
16,696.92
11,956.86
13,228.83
9,499.31
4,798.12
5,623.90

Solvency Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Debt to Equity info
--
--
--
--
--
--
Short term debt to equity ratio info
--
--
--
--
--
--
Current Ratio info
5.21
4.14
4.97
4.37
2.33
2.85
Quick Ratio info
3.85
3.12
3.53
2.85
1.74
2.16
Interest Coverage info
148.49
140.86
271.97
409.34
1,150.19
21.20

Operating Efficiency Ratios

TTM Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17
Debtors to sales (%) info
41.42
42.05
40.63
33.52
37.33
31.72
Asset Turnover info
0.70
0.65
0.66
0.68
0.72
0.84
Receivable days info
--
144.58
132.12
125.30
124.34
111.01
Inventory Days info
--
96.67
102.08
101.28
94.11
88.40
Payable days info
--
135.45
133.54
149.95
136.29
94.72
Cash Conversion Cycle info
--
105.80
100.66
76.63
82.16
104.69
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...